Boston Trust Walden Corp Acquires 95 Shares of AMETEK, Inc. (NYSE:AME)

Boston Trust Walden Corp boosted its holdings in shares of AMETEK, Inc. (NYSE:AME) by 0.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 68,265 shares of the technology company’s stock after purchasing an additional 95 shares during the quarter. Boston Trust Walden Corp’s holdings in AMETEK were worth $12,305,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in AME. Oddo BHF Asset Management Sas acquired a new stake in shares of AMETEK in the third quarter worth $3,724,000. Everence Capital Management Inc. acquired a new stake in AMETEK in the 4th quarter worth $999,000. BNP Paribas Financial Markets increased its holdings in shares of AMETEK by 23.2% during the 3rd quarter. BNP Paribas Financial Markets now owns 355,828 shares of the technology company’s stock worth $61,099,000 after purchasing an additional 67,025 shares during the period. Taurus Asset Management LLC raised its position in shares of AMETEK by 2.9% during the third quarter. Taurus Asset Management LLC now owns 115,033 shares of the technology company’s stock valued at $19,752,000 after buying an additional 3,210 shares during the last quarter. Finally, Czech National Bank lifted its stake in shares of AMETEK by 6.3% in the fourth quarter. Czech National Bank now owns 50,153 shares of the technology company’s stock valued at $9,041,000 after buying an additional 2,987 shares during the period. Institutional investors and hedge funds own 87.43% of the company’s stock.

Insider Buying and Selling

In other news, insider David F. Hermance sold 6,243 shares of the company’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $190.99, for a total transaction of $1,192,350.57. Following the completion of the transaction, the insider now directly owns 36,731 shares of the company’s stock, valued at $7,015,253.69. This represents a 14.53 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Emanuela Speranza sold 6,747 shares of the firm’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $195.90, for a total transaction of $1,321,737.30. Following the completion of the transaction, the insider now directly owns 30,460 shares of the company’s stock, valued at approximately $5,967,114. This trade represents a 18.13 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 29,200 shares of company stock valued at $5,707,620. 0.61% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research firms have commented on AME. Bank of America raised AMETEK from a “neutral” rating to a “buy” rating and upped their price target for the company from $195.00 to $225.00 in a report on Monday, December 16th. Mizuho raised their target price on AMETEK from $190.00 to $200.00 and gave the stock an “outperform” rating in a research report on Friday, November 1st. KeyCorp lifted their price target on shares of AMETEK from $205.00 to $215.00 and gave the stock an “overweight” rating in a research note on Friday, November 22nd. StockNews.com upgraded shares of AMETEK from a “hold” rating to a “buy” rating in a research note on Tuesday, January 28th. Finally, BNP Paribas upgraded shares of AMETEK from a “neutral” rating to an “outperform” rating and set a $210.00 target price on the stock in a research report on Thursday, January 16th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $203.44.

AMETEK Stock Down 0.1 %

Shares of NYSE AME opened at $184.44 on Tuesday. AMETEK, Inc. has a 52-week low of $149.03 and a 52-week high of $198.33. The company has a debt-to-equity ratio of 0.18, a quick ratio of 0.84 and a current ratio of 1.39. The stock has a market cap of $42.66 billion, a P/E ratio of 32.13, a P/E/G ratio of 2.67 and a beta of 1.16. The firm has a 50 day moving average price of $185.44 and a 200 day moving average price of $176.41.

AMETEK Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 20th. Investors of record on Friday, December 6th were given a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date was Friday, December 6th. AMETEK’s dividend payout ratio is currently 19.51%.

About AMETEK

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.